Abstract
Anti-RhD prophylaxis of haemolytic disease of the fetus and newborn (HDFN) is highly effective, but as the suppressive mechanism remains uncertain, a mouse model would be of interest. Here we have generated transgenic mice expressing human RhAG and RhD erythrocyte membrane proteins in the presence and, for human RhAG, in the absence, of mouse Rhag. Human RhAG associates with mouse Rh but not mouse Rhag on red blood cells. In Rhag knockout mice transgenic for human RHAG, the mouse Rh protein is "rescued" (re-expressed), and co-immunoprecipitates with human RhAG, indicating the presence of hetero-complexes which associate mouse and human proteins. RhD antigen was expressed from a human RHD gene on a BAC or from RHD cDNA under control of β-globin regulatory elements. RhD was never observed alone, strongly indicative that its expression absolutely depends on the presence of transgenic human RhAG. This first expression of RhD in mice is an important step in the creation of a mouse model of RhD allo-immunisation and HDFN, in conjunction with the Rh-Rhag knockout mice we have developed previously.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Ammonium Compounds / metabolism
-
Animals
-
Blood Proteins / chemistry
-
Blood Proteins / genetics*
-
Blood Proteins / metabolism
-
Cation Transport Proteins / genetics
-
Cation Transport Proteins / metabolism
-
Cell Line
-
Erythrocyte Membrane / metabolism
-
Erythrocytes / metabolism
-
Gene Expression Regulation
-
Gene Expression*
-
Humans
-
Male
-
Membrane Glycoproteins / chemistry
-
Membrane Glycoproteins / genetics*
-
Membrane Glycoproteins / metabolism
-
Mice
-
Mice, Knockout
-
Mice, Transgenic
-
Promoter Regions, Genetic
-
Protein Binding
-
Protein Multimerization
-
Rh-Hr Blood-Group System / chemistry
-
Rh-Hr Blood-Group System / genetics*
-
Rh-Hr Blood-Group System / metabolism
-
Transcription, Genetic
-
beta-Globins / metabolism
Substances
-
Ammonium Compounds
-
Blood Proteins
-
Cation Transport Proteins
-
Membrane Glycoproteins
-
RHAG protein, human
-
Rh-Hr Blood-Group System
-
Rho(D) antigen
-
beta-Globins
Grants and funding
N.d.S. and U.C. were supported by post-doctoral funding from Laboratoire Français du Fractionnement et des Biotechnologies, France. This work was supported by grants from the Association Recherche Transfusion (Contracts 25-2001 and 34-2003) (
http://www.art-hemobiologie.org/) and the GIS Maladies Rares (support for part of the initial analysis of the Rh/Rhag knockout mouse models at the ICS) (
http://fondation-maladiesrares.org/). No individuals employed or contracted by the funders (other than the named authors) played any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.